INNOVATE Corp. (NYSE:VATE – Get Free Report) was the target of a large decline in short interest during the month of September. As of September 15th, there was short interest totalling 217,800 shares, a decline of 13.0% from the August 31st total of 250,400 shares. Approximately 4.4% of the shares of the stock are sold short. Based on an average trading volume of 57,600 shares, the short-interest ratio is presently 3.8 days.
INNOVATE Trading Up 1.0 %
NYSE:VATE opened at $3.95 on Friday. The stock’s 50-day moving average is $3.03 and its 200-day moving average is $1.48. INNOVATE has a 1-year low of $3.53 and a 1-year high of $16.90. The stock has a market cap of $51.55 million, a P/E ratio of -7.05 and a beta of 2.47.
INNOVATE (NYSE:VATE – Get Free Report) last posted its earnings results on Wednesday, August 7th. The company reported $0.10 earnings per share for the quarter. The business had revenue of $313.10 million for the quarter.
Institutional Trading of INNOVATE
INNOVATE Company Profile
INNOVATE Corp., through its subsidiaries, operates in infrastructure, life sciences, and spectrum areas in the United States. The Infrastructure segment provides industrial construction, structural steel, and facility maintenance services, such as fabrication and erection of structural steel and heavy steel plate services, and large-diameter water pipes and water storage tanks; fabrication of trusses and girders; and 3-D building information modeling and detailing for commercial, industrial, and infrastructure construction projects, such as buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, metal processing, refineries, pulp and paper mills, and power plants.
Featured Stories
- Five stocks we like better than INNOVATE
- How to Capture the Benefits of Dividend Increases
- CarMax’s Impressive Rally: What Investors Should Watch Next
- What is an Earnings Surprise?
- MarketBeat Week in Review – 9/23 – 9/27
- Why Are Stock Sectors Important to Successful Investing?
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for INNOVATE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INNOVATE and related companies with MarketBeat.com's FREE daily email newsletter.